| Cell-penetrating peptides: 20 years later, where do we stand? C Bechara, S Sagan FEBS letters 587 (12), 1693-1702, 2013 | 1054 | 2013 |
| Translocation and endocytosis for cell-penetrating peptide internalization CY Jiao, D Delaroche, F Burlina, ID Alves, G Chassaing, S Sagan Journal of Biological Chemistry 284 (49), 33957-33965, 2009 | 389 | 2009 |
| The human sperm protein PH-20 has hyaluronidase activity M Gmachl, S Sagan, S Ketter, G Kreil FEBS letters 336 (3), 545-548, 1993 | 183 | 1993 |
| Different membrane behaviour and cellular uptake of three basic arginine-rich peptides A Walrant, I Correia, CY Jiao, O Lequin, EH Bent, N Goasdoué, ... Biochimica et biophysica acta (BBA)-biomembranes 1808 (1), 382-393, 2011 | 179 | 2011 |
| Cell‐surface thiols affect cell entry of disulfide‐conjugated peptides S Aubry, F Burlina, E Dupont, D Delaroche, A Joliot, S Lavielle, ... The FASEB Journal 23 (9), 2956-2967, 2009 | 178 | 2009 |
| Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution ID Alves, N Goasdoué, I Correia, S Aubry, C Galanth, S Sagan, S Lavielle, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1780 (7-8), 948-959, 2008 | 158 | 2008 |
| Tryptophan within basic peptide sequences triggers glycosaminoglycan‐dependent endocytosis C Bechara, M Pallerla, Y Zaltsman, F Burlina, ID Alves, O Lequin, ... The FASEB Journal 27 (2), 738-749, 2013 | 147 | 2013 |
| Lipid reorganization induced by membrane-active peptides probed using differential scanning calorimetry P Joanne, C Galanth, N Goasdoué, P Nicolas, S Sagan, S Lavielle, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1788 (9), 1772-1781, 2009 | 142 | 2009 |
| Quantification of the cellular uptake of cell‐penetrating peptides by MALDI‐TOF mass spectrometry F Burlina, S Sagan, G Bolbach, G Chassaing Angewandte Chemie 117 (27), 4316-4319, 2005 | 137 | 2005 |
| Isolation of dermenkephalin from amphibian skin, a high‐affinity (δ‐selective opioid heptapeptide containing a D‐amino acid residue A Mor, A Delfour, S Sagan, M Amiche, P Pradelles, J Rossier, P Nicolas FEBS letters 255 (2), 269-274, 1989 | 129 | 1989 |
| N-and Cα-methylation in biologically active peptides: synthesis, structural and functional aspects S Sagan, P Karoyan, O Lequin, G Chassaing, S Lavielle Current medicinal chemistry 11 (21), 2799-2822, 2004 | 127 | 2004 |
| Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. S Sagan, G Chassaing, L Pradier, S Lavielle Journal of Pharmacology and Experimental Therapeutics 276 (3), 1039-1048, 1996 | 125 | 1996 |
| Peptide‐grafted nanodiamonds: preparation, cytotoxicity and uptake in cells S Vial, C Mansuy, S Sagan, T Irinopoulou, F Burlina, JP Boudou, ... ChemBioChem 9 (13), 2113-2119, 2008 | 122 | 2008 |
| Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study ID Alves, C Bechara, A Walrant, Y Zaltsman, CY Jiao, S Sagan PloS one 6 (9), e24096, 2011 | 118 | 2011 |
| The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides ML Jobin, M Blanchet, S Henry, S Chaignepain, C Manigand, S Castano, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1848 (2), 593-602, 2015 | 116 | 2015 |
| Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass … F Illien, N Rodriguez, M Amoura, A Joliot, M Pallerla, S Cribier, F Burlina, ... Scientific Reports 6 (1), 36938, 2016 | 107 | 2016 |
| Tracking a new cell-penetrating (W/R) nonapeptide, through an enzyme-stable mass spectrometry reporter tag D Delaroche, B Aussedat, S Aubry, G Chassaing, F Burlina, G Clodic, ... Analytical chemistry 79 (5), 1932-1938, 2007 | 106 | 2007 |
| A direct approach to quantification of the cellular uptake of cell-penetrating peptides using MALDI-TOF mass spectrometry F Burlina, S Sagan, G Bolbach, G Chassaing Nature protocols 1 (1), 200-205, 2006 | 106 | 2006 |
| Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. M Amiche, S Sagan, A Mor, A Delfour, P Nicolas Molecular pharmacology 35 (6), 774-779, 1989 | 106 | 1989 |
| Anandamide and WIN 55212‐2 inhibit cyclic AMP formation through G‐protein‐coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes S Sagan, L Venance, Y Torrens, J Cordier, J Glowinski, C Giaume European Journal of Neuroscience 11 (2), 691-699, 1999 | 105 | 1999 |
fabienne burlinaCR CNRS Laboratoire des Biomolécules, Sorbonne Universités, CNRS, ENSVerifierad e-postadress på upmc.fr
